Covaxin

Delhi Runs Out Of Covishield; Maharashtra, MP Also Complain Of Vaccine Shortage

'Covaxin Found To Be 77.8% Effective In Final Analysis Of Phase III Trials', Claims Bharat Biotech

Clear Covaxin, Covishield Or We Won't Accept Your Vaccine Certificates: India To EU

Covaxin Effectively Neutralises Covid-19's Alpha & Delta Variant: US Health Research Institute

'Pricing Clearly Established For Supplies Outside India': Bharat Biotech On Brazil Covaxin Deal Controversy

Brazil To Suspend USD 324 Million Covaxin Vaccine Deal Over Accusations Of Irregularities

Moderna Becomes Fourth Vaccine To Get Approval In India. Here’s A Quick Peek On The Other Three

Cipla Gets DCGI Nod To Import Moderna's Covid Jab For Emergency Use In India

Brazil Govt Faces Probe For Choosing Bharat Biotech's Covaxin Deal Over 'Cheaper' Pfizer Vaccine | All About Controversy

After Criticising Centre Over Covaxin's WHO Approval, CM Mamata Writes To PM Modi Seeking Intervention

CM Mamata Hits At Centre, Says: Get Covaxin Authorised By WHO Or Take Responsibility Of Students

Covaxin Phase 3 Trial Data Shows 77.8% Efficacy, Gets Approval From DCGI's Expert Panel